Amgen Inc. Indenture Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (March 2023)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2023
Amgen Inc. Officer’s Certificate Relating to Issuance of Senior Notes Due 2029, 2033, and 2053
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2022
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2029, 2032, 2052, 2062) under Indenture with The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2022
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes Due 2028, 2032, 2041, and 2052
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2021
Officer’s Certificate of Amgen Inc. Relating to 2.770% Senior Notes Due 2053
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2020
Amgen Inc. Officer’s Certificate for 2.300% Senior Notes Due 2031
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2020
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2025–2050)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2020
Officer’s Certificate of Amgen Inc. Relating to 3.200% Senior Notes Due 2027
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2017
Amgen Inc. Officer’s Certificate for Issuance of Senior Notes (2019, 2020, 2022) under Indenture
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2017
Officer’s Certificate Relating to Issuance of Amgen Inc. Senior Notes (2021, 2023, 2026)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2016
Officer’s Certificate of Amgen Inc. Relating to Issuance of 4.563% Senior Notes Due 2048 and 4.663% Senior Notes Due 2051
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2016
Officer’s Certificate of Amgen Inc. Relating to Issuance of 1.250% Senior Notes Due 2022 and 2.000% Senior Notes Due 2026
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2016
Officer’s Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2014)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2014
Amgen Inc. Indenture Agreement with The Bank of New York Mellon Trust Company, N.A. (May 22, 2014)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2014
Officers' Certificate of Amgen Inc. Relating to 2.125% Senior Notes Due 2019 and 4.000% Senior Notes Due 2029
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2012
Officers' Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2017, 2022, 2043)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2012
Officers' Certificate of Amgen Inc. Relating to Issuance of Senior Notes (2016, 2021, 2042)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2011
Officers' Certificate of Amgen Inc. Relating to 3.45% Senior Notes Due 2020 and 4.95% Senior Notes Due 2041
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2010
Officers' Certificate of Amgen Inc. Relating to Issuance of 4.50% Senior Notes Due 2020 and 5.75% Senior Notes Due 2040
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2010
Officers' Certificate of Amgen Inc. Relating to Issuance of 5.70% Senior Notes Due 2019 and 6.40% Senior Notes Due 2039
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2009
Officers' Certificate of Amgen Inc. Relating to Issuance of 6.15% Senior Notes Due 2018 and 6.90% Senior Notes Due 2038
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2008
Agreement of Resignation, Appointment and Acceptance among Amgen Inc., The Bank of New York, and Citibank, N.A. (February 15, 2008)
Indenture Agreements
Amgen Inc.
Biotechnology
2008
Officers' Certificate of Amgen Inc. Relating to Issuance of Senior Notes (May 30, 2007)
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2007
Amgen Inc. $2,500,000,000 0.375% Convertible Senior Notes Due 2013 Indenture with JPMorgan Chase Bank, N.A.
Indenture Agreements
Amgen Inc.
Biotechnology
DE
2006
Amgen Inc. and JPMorgan Chase Bank, N.A. Indenture for $2.5 Billion 0.125% Convertible Senior Notes Due 2011
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2006
Indenture Agreement for 0.375% Convertible Senior Notes due 2013 between Amgen Inc. and JPMorgan Chase Bank, N.A.
Indenture Agreements
Amgen Inc.
Biotechnology
DE
2006
Amgen Inc. and JPMorgan Chase Bank, N.A. Indenture for 0.125% Convertible Senior Notes Due 2011
Indenture Agreements
Amgen Inc.
Biotechnology
DE
2006
First Supplemental Indenture to Indenture for Amgen Inc. Liquid Yield Option Notes due 2032 (Zero Coupon – Senior) between Amgen Inc. and LaSalle Bank National Association,...
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2005
Amgen Inc. Officers' Certificate Relating to 4.00% Senior Notes Due 2009 and 4.85% Senior Notes Due 2014
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2004